NIXT China Summit   In the past few years, there have been tremendous breakthroughs in the technology sector. Emerging technologies such as artificial intelligence, metaverse, 5G, blockchain, Internet of Things, AR/VR have brought new opportunities and momentum, and the wave of digital transformation is spreading across all industries. Using emerging technologies has become a development key point that every enterprise must consider and prioritize. How can enterprises quickly grasp emerging technologies to drive their own business digital transformation? How can they explore markets through emerging technologies and establish new business models?   From July 19th to 21st, 2023, the NIXT China Summit was successfully held at the National Convention Center in Beijing. The conference focused deeply on emerging technologies, connecting all stakeholders in enterprise digital transformation, and conducted exchanges and discussions on six vertical industries: artificial intelligence, smart cities, finance, advanced manufacturing, logistics, and retail, providing assistance for industry and enterprise digital transformation.   Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") was invited to attend the conference. According to the "China Data Element Market Development Report (2021-2022)" by the China Industry and Information Security Administration, enterprises that achieve digitization can maintain a 41.2% increase in business growth, a 42.8% increase in production efficiency, and a 15.3% reduction in product research and development cycles. With the acceleration of the wheels of the digital economy era, the gap between leading and lagging digital enterprises will continue to widen. Enterprise digital transformation is inevitable, not an option. Digitization is an important lever to help traditional enterprises transform into new forms and an inevitable choice to support the strategic development of companies. Enterprises should leverage digital technology to build unique competitiveness and disrupt existing markets with new products and services. The development of information and communication technology and industrial technology has continuously promoted the continuous growth and expansion of China's digital economy. China is experiencing a new wave of digital transformation. Currently, developing the digital economy has been elevated to the level of national strategy, with the State Council and the Ministry of Industry and Information Technology successively introducing favorable policies to promote enterprise digital transformation, such as the "14th Five-Year Plan" which clearly states the goal of "creating new advantages in the digital economy." At the same time, Enterprises are also achieving digital transformation by continuously increasing IT investment. In 2022, Chinese enterprises' IT expenditure reached $345.53 billion, and it is expected to continue growing steadily in the future, with China's IT expenditure expected to reach $460.64 billion by 2027.   In addition, with the continuous decline in birth rates combined with an increase in average life expectancy, China has entered a moderately aging society. The increasing aging rate and the gradual decrease in the proportion of working-age population have led to an increase in labor costs in China's manufacturing industry. As a tool to reduce the demand for the number of workers during production and improve quality and efficiency, the demand for digital transformation technology will increase accordingly. It is expected that in the future, as China's aging problem deepens further, the proportion of working-age population in China will continue to show a downward trend.   Digital technology has penetrated into all aspects of social and economic life, and the new economy will become an important support point for economic growth. In the face of the wave of digital economic development, it is necessary for China to seize development opportunities, drive the transformation of traditional industries, promote high-quality economic development, build a new development pattern, and achieve the rise of a great nation.   According to Frost & Sullivan research, looking at the current digital transformation status of major industries in China, the service industry currently has the highest penetration rate of digitization. Since the tertiary industry has always been a key area of digital transformation, its level of digitization and speed of digital transformation rank first among the three major industries, far higher than the digitization process of agriculture and industry. In the future, the pace of digitization in agriculture and industry will accelerate. With the maturity of 5G infrastructure, combined with the integration of new infrastructure such as industrial Internet, Internet of Things, and cloud computing from pilot construction to integrated applications, digital technology will penetrate deep into the tertiary industry, while accelerating its penetration into the secondary and primary industries, with development dividends expected to radiate into sub-sectors such as smart factories, smart energy, and smart agriculture.   However, it should be noted that although the current digital transformation penetration rate in China has been comprehensively improved, there is still a dilemma of high failure rates, making successful digital transformation for Chinese enterprises a long and arduous journey. The main problems at this stage are manifested in the lack of systematic and holistic awareness of digital transformation among enterprises, the lack of a systematic transformation framework that prevents them from implementing digital strategies, and the lack of effective measurement mechanisms.   Enterprises' digital transformation mainly includes the construction of digital cultural organizations and digital technology platforms. Successful digital enterprises rely on a complete strategy, through more agile business processes, interconnected platforms, analysis tools, and collaboration capabilities to improve production efficiency, thereby achieving a more lean and agile operational model.   For example, digital procurement is an important means to help enterprises reduce costs and increase efficiency, and accumulate core data assets. Compared with traditional offline procurement, the platform-based procurement model has prominent advantages, as it can present procurement information in a data form, reducing procurement costs and featuring high efficiency and transparency; digital supply chains can integrate and optimize enterprise supply chains, covering multiple links from suppliers to end-users, including raw material procurement, production, warehousing, logistics, sales, etc. By improving upstream and downstream supply chain relationships and integrating and optimizing information flow, logistics, capital flow, etc. in the supply chain, enterprises can enhance their competitive advantage. In summary, enterprise digital transformation is not only a trend but also an inevitable choice for enterprises to improve competitiveness and development. Digital transformation will lead enterprises into the future.

Data shows, this year 618 During this period, the transaction scale of the beauty and skincare market in comprehensive e-commerce slightly decreased year-on-year 2.3% ; Live e-commerce has witnessed rapid growth, especially on Douyin 618 The transaction volume of beauty products during this period exceeded 156 Yuan, a year-on-year increase 69% Specifically, on the comprehensive e-commerce platform, Perlane has maintained a Tmall ranking for two consecutive years 618 beauty and skin care Top 5 , rose to the number 4 Name, overwhelming OLAY Traditional leading brands; Vichy remains at the top this year 10 Name location.   2022 In [year], on the Taobao and Tmall platforms alone, eight major domestic brands achieved a scale breakthrough 10 Yuan, emerging brand Zhibenhe HBN (YoY growth exceeds 80% ) are among them.   In the domestic beauty market, in addition to leading brands holding their ground, emerging domestic brands are gradually developing and growing, participating in competition with first-tier brands at home and abroad.   Frost & Sullivan Frost & Sullivan Wu Yunhan, a consumer industry analyst at Frost & Sullivan in Greater China (hereinafter referred to as 'Frost & Sullivan'), was interviewed by Bullet Finance to discuss the development of emerging domestic beauty brands.   * Click "Read the Original Article" at the end of the text to read the full report. Bullet Finance Q In the past two years, in addition to leading domestic beauty brands, many new entrants have also achieved explosive growth. For example, Zhiben. HBN such as Grain Rain, 2022 The annual transaction volume of Tmall beauty products is at 10 For brands worth over 100 million yuan, apart from KuaDi under Huaxi Biology, there are also Zhiben. HBN The year-on-year growth rate is expected to be at 60% , 80% Above. This year 618 , HBN Gu Yu has entered the Douyin skincare category Top 20 The list includes brands with transaction volumes exceeding those of big names such as Jiao Yun Shi and Kie Yan Shi. How do emerging domestic brands view their rapid rise? What factors have contributed to these brands achieving faster growth rates than leading brands? Does the rise of emerging brands have reference value for the development of the domestic beauty market?   The rise of domestic brands is, on the one hand, due to the market opportunities unleashed by trillion-dollar beauty products in China. On the other hand, through 20 After years of refining and accumulation in the foundational layer, domestic beauty products have evolved from ensuring product safety to emphasizing efficacy. At the same time, the changing consumption concepts of new-generation consumers have also broadened the imagination space for domestic beauty products. Growth drivers: 1 The intergenerational migration of consumer groups is the underlying logic behind the rise of domestic brands and beauty products. As Z As the era enters the beauty consumption market, its personalization and confidence in local brands are also driving a reshaping of the beauty industry landscape. Consumers are increasingly pursuing high quality and cost-effective products when facing Chinese brands. This has inspired domestic brands to establish their own sense of quality in product research and development and promotion, continuously enhancing their reputation to win more consumer favor. 2 In the mature market of beauty and skincare, there are many existing market participants with high competition. Domestic brands have made certain upgrades and transformations to traditional brands through new consumer group selection, new market positioning, product innovation, new scenarios, and new communication channels. For example, 'Perfect Diary' has made intensive marketing investments on new media channels, accumulating a large number of high-quality user reviews and brand word-of-mouth in terms of creative design, placement management, post- on data feedback, or refined platform operations. 3 In mature consumer categories with high market demand and fierce competition, domestic brands choose to avoid competition within broad categories and instead enter into niche segments. At the same time, these niche segments lack strong brands, providing certain development space for emerging brands. Brands wait until the niche segments mature before expanding into other categories to build brand awareness. For example, domestic beauty brands such as Poreless, Vichy, and Huarun Biotech follow the strategy of international big brands with large product lines, gradually driving up sales, average order value, and brand recognition through core products. The most typical examples are Poreless' Ruby series and Vichy's Special Care Cream. The rise of emerging brands holds certain reference value for the development of domestic beauty and skincare markets: 1 Looking at the entire market, z Generations are becoming the main force in consumption, and brand operation capabilities are particularly important. Among them, the domestic beauty brand "Zhuben," which focuses on the makeup remover market, has caught up with the favorable trend of live e-commerce in terms of omnichannel operation capabilities. It became popular on Li Jiaqi's live streaming channel. They also seized the opportunity of optimizing the e-commerce distribution system and penetrated into 100 Multiple stores have completed the deployment of their distribution system, and at the same time, brand accounts on other short video platform channels have been established and are being fully rolled out across all channels. 2 Another current trend is the rise of the functional skincare market, HFP As the first skincare brand in China to focus on the concept of original extracts (single high-concentration skincare ingredient essences), it has quickly gained the favor of ingredient enthusiasts. With the continuous growth in consumers' demand for professional efficacy and the catalysis brought about by channel development, we believe that functional skincare is expected to continue to be an important driving force for the overall high growth of domestic cosmetics in the future. 3 In recent years, domestic beauty brands have also been expanding their brand footprint through investments, acquisitions, and other means. As domestic beauty brands develop to a certain stage, they are also planning to enter the high-end market and establish a multi-brand development strategy. Brands like 'Perfect Diary', which are familiar to many, are examples of this. 2021 In 2019, it acquired a skincare brand targeting the high-end market Eve Lom The average unit price is mostly around four or five hundred to a thousand yuan. Q 2022 Since [start year], the beauty market has been overall declining. The market recovery this year has also fallen short of expectations. Online traffic has peaked, and competition in the efficacy skincare sector has become increasingly fierce. In this context, for emerging domestic beauty brands, is there still an opportunity to catch up with first-tier brands? What problems exist? Are there any brands that are more promising? In recent years, emerging beauty brands have ridden on the wave of traffic dividends and, with the support of various capitals, used new thinking and marketing strategies to re-run major professional sub-sectors across new channels and media, making rapid progress. However, as capital gradually leaves, traffic dividends disappear, competition intensifies, and traffic costs become increasingly high. Emerging brands have not yet built a strong product moat and their brand effect has not yet materialized, posing significant challenges at this time. To become a brand, the top priority for emerging beauty brands is to create a unique, solid, and stable product moat. Currently, the entire new and emerging domestic beauty industry still lacks in terms of product strength, research and development, and core technologies. Although powerful cosmetic brands can acquire other brands and factories by purchasing them, it is difficult to simply invest money in acquiring core technologies, as the root cause lies in the scarcity of industry R&D talent. New brands aiming to build a moat and develop exclusive core technologies should 'trace back upstream' and innovate with new raw materials and technologies. Recently, I've been paying attention to the skincare brand "Runbailan" under Huaxi Biotech. This year 618 "Acceleration" has been achieved. According to data released by brands and major platforms, this year 618 During this period, we achieved over 3.56 Yuan billion, an increase compared with the same period last year 54 % thanks to Huaxi Biology 20 With years of research and development in hyaluronic acid, "Runbailian" has always endowed the product with unique competitive advantages, achieving trend-setting leadership in the hyaluronic acid market through innovation and differentiation 10 In the year, we adhered to the market strategy of developing major products, laying the foundation for the emerging market of sublimated essence and bringing more possibilities to future development. * This interview was published in Bullet Finance   Reporter: Hu Fangjie    Original title:    beauty 10 Yi Club, two new members have arrived    >>     .   2023 Frost & Sullivan's New Investment Conference

I IBI EXPO 2023 Biological innovative drugs have become a battleground for the biopharmaceutical industry. In the 'post-pandemic era' when domestic companies continue to invest in innovative drug research and development, differentiated development, indication selection, combination therapy, external cooperation, etc., have increasingly become important ways to enhance the competitiveness of companies in new drug research and development. They are also the main path for domestic pharmaceutical companies to go global and engage in competitive globalization. In addition, a complete and mature supply chain is indispensable for industry development. How to select the most suitable raw materials, consumables, and equipment throughout the entire life cycle of new drug research and development has always been a challenge for companies. In today's world where global supply chains are still fragile, CDMO The domestic substitution of supply chains has become a new perspective for many companies in the industry to focus on for achievement transformation. To further promote the development of China's biopharmaceutical industry, assist startups in transforming their technological achievements, and deeply understand the global trends in the development of the biopharmaceutical industry, organized by the Shanghai Biopharmaceutical Industry Promotion Center and MedMakers Media IBI EXPO 2023 The International Bio-Innovative Drugs Industry Conference is held at 7 month 13 - 15 The day witnessed the grand opening of the Shanghai Cross-border Procurement Exhibition Center.   current session IBI EXPO Set proximity 10,000 meters   2   Exhibition scale, concentration 100+ Well-known brand manufacturer in the supply chain pharmaceutical industry; by 200+ authority PI Led by industry leaders, passionately crafted 18+ The thematic forum comprehensively covers the current industry's hot topics and cutting-edge developments. A multitude of guests, including government representatives, corporate executives, renowned industry experts, and investors, gather together to participate in the industry's grand event and seek common development for the industry. Swipe left and right to view photos of the scene Frost & Sullivan Frost & Sullivan As the strategic partner of this year's conference, Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, attended the conference, participated in the Second Rare Disease Drug Development Forum and China Biotech company IPO listing Special forum on 2022 - 2023 Biotechnology Market Investment and Financing Analysis' speech was delivered, followed by participation in a roundtable forum, where experts from various industries discussed the current state and development opportunities of the Hong Kong capital market with each other. Partner and Managing Director of Frost & Sullivan Greater China Region fattening Overall   Biomedical market   Investment and financing situation   The number and amount of investment and financing events in China's primary market are as follows: 2021 year, 2020 Peaks are reached annually, followed by a decline. 2022 year, 2023 H1 Biopharmaceutical industry financing Top 5 The amounts all exceed 5 Yi billion yuan, mainly for protein drugs. Looking at sub-sectors, the total financing amount for monoclonal antibody drugs closely follows that of small molecules. New therapies such as cells, genes, and nucleic acids receive high attention, with more than 60 pieces. Data shows that the investment and financing rounds in China's primary market are mainly concentrated in A Previously, there was an overall trend towards earlier financing rounds. The secondary market trends in Hong Kong, Mainland China, and the US were consistent, with valuations pulling back, which also affected the financing situation in the primary market to a certain extent.   Medical device market   of   The total amount of investment and financing is then 2020 Year-over-year leap and 2021 Peaking at the end of the year, 2023 H1 Gradually slowing down. Looking at sub-sectors, robotics, surgical instruments, and artificial organs rank among the top three in terms of total investment and financing. Similar to the biopharmaceutical sector, investment and financing events in the medical device sector are also mainly concentrated in A In the earlier stages, the proportion was on average greater than 70% While the secondary market valuations in both the mainland and Hong Kong have corrected, the primary market has returned to rationality. 2018 till 2023 H1 Hong Kong stocks 18A And the fifth set listed on the Sci-tech Innovation Board 15 Home medical device company, listed on the Hong Kong stock market 18A exist 14 Enterprises go public, Sci-tech Innovation Board No. 5 wrapped 1 Enterprises go public.   Mao Hua pointed out,   Affected by macro factors such as the Fed's interest rate hikes and the fading of "epidemic-driven" effects, coupled with domestic industry factors such as severe homogenization in the biotechnology field and still weak self-sustaining capabilities, the primary and secondary investment and financing markets for biotechnology in China are in 2022 The callback starts at the beginning of the year. 2023 H1 The industry has reached a peak, with both volume and value declining severely, but it has also contributed to the rational development of the industry.     In the future, innovative biotech companies will have more diverse listing options on the secondary market (Hong Kong stock market 18A The secondary market, including the Sci-tech Innovation Board (STAR Market), Growth Enterprise Market (GEM), and Beijing Stock Exchange (BSE), places more emphasis on and anticipates a company's commercialization capabilities and self-sustaining financing. Overseas expansion capabilities and cooperation with large enterprises are considered key project strengths. Under the chairmanship of Liu Hui, founder of Huize Finance, Mao Hua was joined by Sun Ming, Assistant Vice President of the Hong Kong Exchanges, and the Investment Banking Business Department of Lingfeng Capital Limited CEO Li Dequan, Shenwan Hongyuan (Hong Kong) Managing Director Xie Jinghui, Ernst & Young's China Market Director Li Zhiguang, Partner Zhu Honghe of Beijing Jingtian Gongcheng Law Firm, Partner Chen Haotian of Beijing Tongshang Law Firm, Partner Huang Chengyang of Morgan Lewis Law Firm, Partner Ma Junning of Luo Xiaxin Law Firm, and guest Xia Xia from Beijing Sanliyihé Ze Biotechnology Co., Ltd. gathered together to discuss the current situation and development opportunities of biotech companies in the Hong Kong capital market.   About Frost & Sullivan's Healthcare Practice The Healthcare Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the life sciences. Leveraging the global think tank resources of Frost & Sullivan and its cross-industry business development platform in Greater China, the Healthcare Practice has unique core advantages in healthcare industry investment and financing services.   Frost & Sullivan Healthcare   Has a wide range of corporate clients in China, and in the past 20 In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated. Project types include Knowledge Center projects (in-depth content, promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, strategic consulting, etc. We also cooperate with well-known domestic and international information platforms and investment and financing institutions to offer one-stop solutions for enterprises in specialized sub-sectors such as pharmaceuticals and medical devices. Our services have received wide attention from investors. 2023 Frost & Sullivan's New Investment Conference

New Drug Launch and Commercialization Forum 2023 year 7 month 13 - 14 RIO, by Yingfu Chuansi Infotrans The hosted 'Innovative Drugs Launch and Commercialization Forum' was successfully held in Shanghai. The forum aimed to explore the opportunities and challenges faced by the launch and commercialization of innovative drugs. Guests from biotech companies, pharmaceutical enterprises, industry associations, consulting firms, third-party commercialization platforms, investment institutions, law firms, etc., shared industry insights from their respective perspectives. The content covered topics such as the market environment and policies of innovative drugs, medical insurance negotiations, commercial health insurance, commercial layout, market promotion strategies, innovative drugs' full life cycle management plans, third-party platform empowerment of commercialization, drug exports, commercialization channels, and commercial intellectual property protection. It built a platform for industry communication and cooperation to help enhance China's commercialization capabilities of innovative drugs.       Frost & Sullivan Frost & Sullivan As one of the forum's co-partners, Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, was invited to attend the event and delivered a speech on 'The Lifecycle Management Solution for Innovative Drugs'.   From left: affairs of the central government of BeiGene & Director of Policy, Mr. Honghao Shi, Senior Partner at Liu Shen Law Firm, Mr. Zongliang Zou   Liangsheng Investment Partner Li Jia, Youdit Biotechnology UltraDx founder, CEO Dong Zengjun, Partner and Managing Director of Frost & Sullivan Greater China Region, Mao Hua     Partner and Managing Director of Frost & Sullivan Greater China Region fattening Mao Hua first shared the background of the development of the innovative drug industry. He pointed out that overall, the scale of China's pharmaceutical market has ranked second globally. Although there have been impacts from multiple rounds of price cuts in centralized procurement and medical insurance, considering favorable factors such as increasing disease burden, population aging, enhanced payment capabilities and diversification of payment methods, as well as an increase in innovative varieties, China's pharmaceutical market is still expected to continue growing in the future. Currently, monoclonal antibodies, bispecific antibodies, ADC Large molecule drugs such as antibody fusion proteins have become an important area of new drug research and development. Clinical trials of innovative therapies represented by cell therapy, gene therapy, nucleic acid drugs, and oncolytic viruses continue to increase. Recently 3 The annual proportion has reached 4.1% .   In terms of sub-sectors, given that both globally and in China, chronic disease burdens are on the rise year by year,    Digestive and metabolic drugs, as well as anti-tumor drugs, occupy an important position in both global and Chinese markets.   Mao Hua stated that the entire lifecycle of a drug is dynamic and evolving. To achieve successful lifecycle management of innovative drugs, pharmaceutical companies need to focus on three winning strategies, namely: 1 )   Efficient market access & Full-cycle price management; 2 Precise marketing strategies; 3 ) Innovate business models.     "Efficient market access and full-cycle price management will be the foundation of innovative drug lifecycle management. Precise marketing strategies can maximize the value of innovative drug products, reach patients more quickly. Business model innovation includes accelerating organizational structure optimization, retail format transformation, and digital marketing," Mao Hua further explained. About Frost & Sullivan's Healthcare Practice The Healthcare Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the life sciences. Leveraging Frost & Sullivan's global think tank resources and cross-industry business development platform in Greater China, Frost & Sullivan Healthcare has unique core advantages in healthcare industry investment and financing services. Frost & Sullivan Healthcare has a wide range of corporate clients in China and in the past 20 In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated. Project types include Knowledge Center projects (in-depth content, promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, strategic consulting, etc. We also cooperate with well-known domestic and international information platforms and investment and financing institutions to provide one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices. Our services have received wide attention from investors. 2023 Frost & Sullivan's New Investment Conference        

EY ESG Research and Study Set Sail   Pay attention to the 'dual carbon' goal and achieve high-quality and sustainable development. With ESG As the concept gains greater popularity and reaches a wider range of people, investors and enterprises are paying more attention to it as a focal point for capital allocation, strategic planning, and investment decisions. All sectors of society are also actively involved. ESG practice. Recently, EY, with the theme of "Ignite Dreams, Empower the Future", ESG The research and study program at the EY Innovation Center has been officially launched. As a proactive actor in further serving national strategies and popularizing sustainable development concepts and practices, EY hopes to discover more young students who are committed to promoting sustainable development goals, serving the needs of the country and society, and contributing to carbon peak and carbon neutrality.       Frost & Sullivan Frost & Sullivan Wang Chenhui, Partner-in-Chief and Executive Vice President of Frost & Sullivan Greater China, Co-founder and President of LeadLeo, was invited to attend the event. From an industry research perspective,   Combined with specific cases, we shared how to explore industry development trends and risks, thereby helping ESG development.   This event was hosted by Gao Xiang, Senior Manager at EY Research Institute, with Wang Chenhui and   Guo Yi, Chairman of EY Research Institute    EY Hua Zhong Region Audit Services Associate Partner Tang Zhehui, EY Research Institute Senior Manager Wang Shengju, EY Greater China Region ESG Office Manager Wang Ning,    Zhang Li, Director of the Communication Center at the Shanghai Yangtze River Delta Business Innovation Research Institute and Chief Executive Officer of the ZhiXin Project    GaoDun's Education Innovation Product Director Fan Yixin and other guests,    Those who are interested in in-depth learning offline or online ESG Thousands of students from various fields of expertise jointly explore hot topics and share cutting-edge insights.   Managing Partner and Executive Vice President of Frost & Sullivan Greater China, Co-founder and President of LeadLeo Wang Chenhui   ESG Practice is highly challenging yet full of opportunities. Starting from the perspective of industry research and combining specific cases, Wang Chenhui shared with everyone how to explore industry development trends and risks, thereby contributing ESG development. He pointed out, 2002 Year-end 2020 year, China N100 enterprise ESG Report disclosure rate from 18% Grew to 80% , more and more enterprises are actively practicing ESG concept    Responding to the dual carbon goal    accelerate ESG Information disclosure    strengthen ESG Capacity building    Promote layout ESG investment. As consulting firms, Frost & Sullivan and LeadLeo believe that the application of industry research is beneficial for solving ESG Some issues in development, such as research on industry development trends, can help solve the problem of unclear indicators, while industry risk identification and assessment can assist in addressing the pain point of insufficient risk awareness. Source: Frost & Sullivan analysis, LeadLeo research institute   Wang Chenhui introduced that Frost & Sullivan provides for enterprises according to their sustainable development needs ESG Strategic consulting, ESG Report writing, ESG Brand consulting, ESG Human resource consulting and other services    utilize ESG Frost & Sullivan empowers enterprise value transformation in all aspects of business value, achieving sustainable growth. He stated that the key to Frost & Sullivan's service to enterprises is to help them further deepen their leadership position in niche areas. By telling better brand stories, they assist enterprises in jointly achieving a transformation from scale to quality, exploring a path for integrated development of innovation chain, capital chain, and industrial chain. In the future, Frost & Sullivan will always uphold the principles of professionalism, rigor, objectivity, and fairness, persist in serving the high-quality development of the country, and support more enterprises towards sustainable development.   LeadLeo has been deeply involved in enterprise research for many years. With rich experience in content production, platform operation and knowledge management, it has built a leading intelligent enterprise research platform ——“BrainPower” in the industry. Knowlengine ™”Knowledge Management and Research Assistance KaaS The system and related key capability base systems and platforms help drive the development of the digital industry, digital technology innovation, digital ecosystem governance, and the cultivation of digital literacy. Over the years, Frost & Sullivan and LeadLeo have actively supported college students' employment and 'mass entrepreneurship and innovation', cultivating and delivering a large number of professionals with research literacy to society, contributing to the sustainable development of industries and the construction of 'Digital China'.     In the face of a once-in-a-century transformation, Frost & Sullivan and LeadLeo, together with EY, will continue to deliver: ESG The concept is to fully leverage our professional strengths, provide high-end and quality services, empower young talents in various fields, and strive to contribute more wisdom and strength to the green transformation and sustainable development of the economy and society. We aim to promote Chinese-style modernization and achieve high-quality development by building momentum and enhancing capabilities.     2023 Frost & Sullivan's New Investment Conference    

The persistently high temperatures have suddenly made power generation during the peak summer season a hot topic of public discussion. 7 month 6 On the same day, Beijing issued its first high-temperature red alert signal for this summer, while power consumption loads in Jiangsu and Zhejiang provinces both exceeded their limits 1 1000 million kilowatts, earlier than last year 19 sky, 8 sky. Research reports show, 2023 year 4 In recent years, the power generation volume in Yunnan Province has been at a relatively low level. If the power supply situation in Yunnan continues to be tight, what impacts will it have on Guangdong's power supply and spot electricity market prices? The industry expects 2023 During the peak summer season of 2023, the power supply and demand situation in East China, Central China, and South China is relatively tight. Based on this forecast of the power consumption situation, what are the main factors that are causing disruptions to the power supply?   Frost & Sullivan Frost & Sullivan Xu Biao, Executive Director of Frost & Sullivan's Greater China Region (hereinafter referred to as 'Frost & Sullivan'), was interviewed by 'Cailianlian' to discuss power supply security.   * Click "Read the Original Article" at the end of the text to read the full report. Cailian Finance & Economics News Agency Q Cailian News Agency Reporter: According to data released by the China Electricity Council, 1 - 5 Monthly hydropower generation of power plants above designated size across the country 3523 1000 million kWh, a year-on-year decrease 19.2% The top three provinces in terms of hydropower generation nationwide are Sichuan, Yunnan, and Hubei, with their combined hydropower generation accounting for 62.8% , with growth rates of -1.5% , -20.8% and -38.4% What's your take on the decline in related data? 1 - 5 The decline in monthly hydropower generation is partly due to the reduced rainfall and less water inflow from major river basins such as the Yangtze and Yellow Rivers this year, resulting in a year-on-year decrease in the cumulative average utilization hours of hydropower generation equipment. 294 hours. On the other hand, it's also due to last year 1 - 5 The main river basins such as the Yangtze River and the Yellow River received relatively abundant rainfall, resulting in a relatively large amount of hydropower generation. Comparing this year with last year 1 - 5 Monthly hydropower generation has seen a significant decline. Q Cailian News Agency Reporter: Cross-regional coordination and mutual assistance in the power market have become one of the methods to ensure power supply. Taking 'Cloud Power Transmission to Guangdong' as an example, Yunnan Province contributes nearly 70% of the power received outside Guangdong Province ( 2022 Annual data). Research reports show, 2023 year 4 In recent years, Yunnan Province's power generation has been at a relatively low level. It was only after reducing the consumption within the province and lowering the amount of electricity sent out that the power supply and demand were balanced. 6 - 8 The month of January is a seasonal peak in electricity consumption in Guangdong Province, which will lead to a sharp increase in the demand for power transmission from Yunnan. If Yunnan's power supply continues to be tight in the future, what impacts will it have on Guangdong's power supply and spot electricity market prices? If the water inflow during the flood season does not increase as expected and the power generation from hydropower in Yunnan does not increase sufficiently, Guangdong's power supply will still face considerable pressure. In the short term, the tight power supply situation in Guangdong Province still needs to be addressed through measures such as increasing inter-provincial mutual assistance within the Southern Power Grid, coordinating with the State Grid for full support, and increasing the supply of thermal coal and gas within Yunnan Province to regulate the operation of thermal power units. In the long run, expanding the installed capacity and power supply within Guangdong Province, especially the supply capabilities of wind and photovoltaic power generation, also requires accelerating progress. The price of electricity spot market is mainly related to the net load curve. The net load curve is the total load curve (including domestic and imported electricity, which is relatively regular) minus imported electricity, and it mainly depends on the curve of imported electricity. Currently, for the power transmitted from Yunnan to Guangdong, medium- and long-term agreements are still signed. If the power supply from Yunnan to Guangdong is insufficient, it will drive up the price of electricity spot market. Q Cailian News Agency Reporter: Industry estimates 2023 During the peak summer season of 2023, the power supply and demand situation in East China, Central China, and the South is relatively tight. Based on this forecast of electricity consumption trends, which factors do you believe are mainly causing disruptions to power supply? Multiple factors such as macroeconomic growth, rapid recovery of industrial production, and high temperatures have led to increased power demand, putting considerable pressure on power supply. In terms of power supply, uncertainties exist in precipitation and the stability of wind and solar resources, which affect the utilization hours of major power sources such as hydropower, wind power, and photovoltaic power. In addition, power generation enterprises also increase the uncertainty of power production and supply in terms of operational efficiency and equipment risks. * This interview is published on the CCB Client.   Reporter for Lu Tingting    Original title: 'Power Market Welcomes High Temperatures "Baking" Tests: Guangdong Emphasizes Demand-Side Response and Cross-Regional Adjustment to Ensure Supply | Directly Addressing Power Supply Guarantee    . 2023 Frost & Sullivan's New Investment Conference    

2023 year 6 month 29 - 30 On the day, the 9th China Biomedical Innovation Cooperation Conference BIO-PHARM 2023 ) and Hua Medicine Ranking 2023 The China Biopharmaceutical Industry Value List Awards Ceremony was held at the Kempinski Hotel in Suzhou Jinji Lake.   Huayi Research Institute has selected and discovered innovative enterprises in the biomedical field that truly have industry influence and growth potential, and is dedicated to creating the Huayi List. 2023 China's Biomedical Industry Value List aims to promote industrial innovation and development. Hua Medicine Ranking 2023 The China Biopharmaceutical Industry Value List includes antibody drugs, innovative therapies, biotechnology, CRO company , CDMO company The selection of six series of pharmaceutical innovation partners is based on the enterprise quantitative growth evaluation criteria refined over many years by the Huayi Research Institute. It combines basic processes such as questionnaire surveys, corporate interviews, data analysis, and verification. The evaluation panel standardizes and quantifies the dynamic data of shortlisted enterprises through processing, thereby selecting the companies with significant industry value for the year and forming an objective third-party evaluation list in the industry. Frost & Sullivan Frost & Sullivan Frost & Sullivan, the abbreviation for 'Frost & Sullivan' Evaluation of Pharmaceutical R&D Partnerships, aims to recognize companies that have made outstanding contributions and performed excellently in the field of biomedicine.   Frost & Sullivan integrates globally. 62 years of consulting experience, 25 Over the years, we have wholeheartedly served the booming Chinese market, using a global perspective to help clients accelerate their business growth and achieve benchmark positions in industry growth, innovation, and leadership. The Greater Health Industry is one of the core areas of focus for Frost & Sullivan's research.   The Healthcare Business Unit of Frost & Sullivan has professional analytical capabilities and rich project experience in the life sciences field. Leveraging the global think tank resources of Frost & Sullivan and its cross-industry business development platform in Greater China, the Healthcare Business Unit has unique core advantages in healthcare industry investment and financing services.   Frost & Sullivan's Healthcare practice has a wide base of corporate clients in China, and in the past 20 In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated.    Project types include Knowledge Center projects (in-depth content, promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, and strategic consulting. We also cooperate with well-known domestic and international information platforms and investment and financing institutions, offering one-stop solutions in specialized fields such as pharmaceuticals and medical devices. Our services have received widespread attention from investors. As one of the important service institutions for Hong Kong-listed companies, industry consultants play a crucial role in the successful listing and financing of enterprises in the biotechnology sector, which has a high technical threshold. As an industry consultant, Frost & Sullivan is deeply involved in both early-stage investment and post-listing activities in the healthcare sector, making it the top choice for healthcare companies seeking to list in Hong Kong.   According to the information disclosed by the Hong Kong Exchanges, 2015 till 2022 In FY, Frost & Sullivan went on to maintain its market-leading position in the Hong Kong-listed consultancy segment for consecutive years. 8 Maintaining a leading position year after year, we have helped the majority of listed companies in the market to remain at the top in their respective segments. We are an absolute leader in serving healthcare companies seeking to go public in Hong Kong.   2019 year A Since the launch of the Sci-tech Innovation Board, Frost & Sullivan's share has reached 72.3% In addition, due to the high demand for business and industry analysis in the fifth set of issues, industry advisory services were systematically adopted. Frost & Sullivan's share of clients served under the fifth set of standards has reached 83.8% (Number of projects).   since 2018 Since the beginning of this year, Frost & Sullivan has successively released    "The ECMO unit Industry Status quo and Development Trend Report    ,    "China Rare Disease Industry Trend Observation Report",    Medical Devices CRO company Industry Status quo and Development Trends Report    "Report on the Current Situation and Development Trends of the Improved New Drug Industry",    "Research Report on the Current Development Status and Future Trends of the Ophthalmic Drug Market",    "White Paper on the Current Industry Situation and Future Development of China's Assisted Reproduction Industry",    Medical Intelligence Industry White Paper    We have contributed to the research and promotion of various sub-industries through multiple white papers, providing important reference perspectives for market investors.   2022 year 9 In January, the first New Investment Expo and the 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit BioTech Investment Forum were successfully held in Shanghai. At the event, the Frost & Sullivan Growth, Innovation and Leadership Awards in the biotech sector were announced, along with the official release of CDMO company Industry Current Situation and Development Trend Research Report". Numerous biotech companies, investment institutions, and professional service providers gathered at the event to focus on new trends in biotech investment and financing, participating in the forum on-site. 180+ People, watching online 2,000+ person.   2023 year 9 month 28 On the 1st, the 2nd New Investment Expo and the 17th Frost & Sullivan Global Growth, Innovation and Leadership Summit Biotechnology Investment Forum will be held again in Shanghai. Frost & Sullivan will continue to leverage its industrial value by building a professional cooperation platform through this forum, stimulating innovation vitality in the biotechnology industry, promoting investment and financing cooperation and resource sharing, and jointly advancing the sustainable development of the pharmaceutical innovation industry with industry partners.   The registration channel for the conference has been officially opened.   Scan the QR code to register for the event      Frost & Sullivan is considered one of the most powerful, professional, and influential industry research institutions in the sector. We aim to work with more biotech companies to gain insights into industry trends, seize development opportunities, jointly promote innovation and upgrading of China's large health industry, and create a healthy future.

To address changes in the policy and operational environment of the pharmaceutical industry, as well as to implement the development requirements put forward by the Ministry of Industry and Information Technology, 2019 Huaren Shuanghe has formulated the 'Huaren Shuanghe's 14th Five-Year Product Development Strategy', aiming to complete the company's strategic transformation towards innovation and realize the vision of 'becoming a world-class pharmaceutical enterprise trusted by the public and driven by innovation'.   7 month 4 Today, Frost & Sullivan Frost & Sullivan Mao Hua, Partner and Managing Director of Frost & Sullivan's Greater China Region, was invited to attend the Mid-Term Planning Seminar for China Resources Shuanghe's 14th Five-Year Plan. He also presented a report on the extension development consulting report for the mid-term strategic review of China Resources Shuanghe's 14th Five-Year Plan, contributing to the strategic transformation of Shuanghe. Partner and Managing Director of Frost & Sullivan Greater China Region fattening   Under the guidance of the principles of leading-edge, similarity and scientificity, the Frost & Sullivan healthcare team has selected top global pharmaceutical companies and leading domestic pharmaceutical companies for benchmarking analysis.     Through benchmark analysis, it can be found that domestic and international pharmaceutical companies have all gone through different stages of development from scale expansion to innovation transformation, with external expansion always being an important means for achieving strategic goals at different stages.      Mao Hua stated that, in light of the company's current situation and benchmarking insights, China Resources Shuanghe should take measures to continuously enhance its project sourcing capabilities, improve organizational structure, and optimize collaboration mechanisms.   About Frost & Sullivan's Healthcare Practice   The Healthcare Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the life sciences. Leveraging Frost & Sullivan's global think tank resources and the cross-industry business development platform in Greater China, Frost & Sullivan Healthcare has unique core advantages in healthcare industry investment and financing services. Frost & Sullivan Healthcare has a wide range of corporate clients in China and in the past 20 In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated. Project types include Knowledge Center projects (in-depth content, promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, strategic consulting, etc. We also cooperate with well-known domestic and international information platforms and investment and financing institutions to provide one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices. Our services have received wide attention from investors. 2023 Frost & Sullivan's New Investment Conference    

chatbot ChatGPT Lifted up artificial intelligence (AI) The surging tide of revolution, from the perspective of economic development, AI How profound will the revolution have an impact on China's economy and capital market, as well as productivity? / How should we view the impact on production efficiency? Is it ultimately possible to significantly boost the profitability of listed companies? China's development AI What major obstacles or challenges may be encountered during the technology phase? In terms of policy, will China introduce a continuous stream of significant policies to drive progress in the future? AI development?   What challenges and opportunities will traditional Chinese internet giants face?   Frost & Sullivan Frost & Sullivan Lu Jing, Partner and Managing Director of Frost & Sullivan's Greater China region, was interviewed by Lufuot about the development trends of artificial intelligence in China. Reuters News Q From the perspective of economic development, what do you think AI How profound will the revolution have an impact on China's economy and capital market, as well as on productivity? / What is the impact on production efficiency? Is it ultimately possible to significantly increase the profitability of listed companies? Witnessing the drive by artificial intelligence AlphaGo Defeating the world Go champion and last year ChatGPT After its sudden emergence, the phenomenonally explosive popularity of artificial intelligence has become an important milestone in the history of human civilization development. Similarly, this revolution driven by artificial intelligence will also have a profound impact on China's economy and capital market.   Firstly, artificial intelligence will significantly improve China's productivity, and the enhancement of production efficiency is gradually upgrading from perceptual intelligence to cognitive intelligence. Perceptual intelligence refers to the ability of computers and different devices to possess human-like perceptual abilities such as vision, hearing, and touch. By structuring and processing multi-source heterogeneous data and communicating with humans through these abilities, the efficiency improvements brought about by perceptual intelligence are already quite common in our daily lives, including face recognition in various scenarios and interactions with digital humans. Cognitive intelligence, on the other hand, draws inspiration from brain-like research and cognitive science based on perceptual intelligence. It combines cross-disciplinary knowledge graphs and other technologies to endow computers and different devices with human-like thinking and cognitive abilities. It is expected that with large-scale pre-trained language models and similar ChatGPT As the products continue to mature, the efficiency improvements brought about by cognitive intelligence will become more widespread.   Secondly, in the long run, the efficiency improvements brought about by artificial intelligence will lead to a transformation in China's labor force structure. Perceptual intelligence will replace low-skilled jobs to a certain extent (including security, telephone customer service, etc.), and such transformations have already been evident in China's business environment. Cognitive intelligence will replace repetitive skill jobs that require simple mental effort to a certain extent (including translation, graphic design, etc.).   Finally, from the perspective of its impact on the capital market, the improvement in labor efficiency and structural transformation of the workforce will be reflected in the capital market. Capital will flow into sectors and enterprises that have the greatest development potential, the most positive impact on human civilization, and that align with the direction of national policy formulation in this artificial intelligence revolution.   The impact on production efficiency is certain. As mentioned earlier, artificial intelligence technologies based on perceptual and cognitive intelligence will continuously improve the efficiency of different tasks. From the perspective of cost reduction and efficiency enhancement brought about by artificial intelligence, it will effectively help listed companies reduce operating costs, including sales expenses and management fees, thereby improving the net profit performance of listed companies and having a positive impact on listed enterprises and the entire capital market. Q China's development AI What major obstacles or challenges may be encountered in technology? In terms of policy, will China introduce a continuous stream of significant policies to drive this forward in the future?   From a technical perspective, computing power, as an important infrastructure for the development of artificial intelligence, especially during the recent phase of concentrated development of large-scale pre-trained language models, has reached a certain level of demand in China. Moreover, the development of computing power will directly affect the level of advancement of artificial intelligence technology in our country. Data is the key to algorithm models, especially when developing large-scale language models, special attention needs to be paid to issues related to personal information protection, including data sources, data processing, data security, and bias induction. Taking models from leading foreign manufacturers as an example, CodeBert , LAMDA Subsequently, there have been revelations of biased, discriminatory, or inappropriate content, including derogatory remarks towards certain groups or distortions in the content or timing of certain topics. The occurrence of such issues is often due to data sources, and the quality of the data sources largely determines the excellence of the model.   From a policy perspective, there is no doubt that China's encouragement for the development of artificial intelligence is substantial. 2017 The "New Generation Artificial Intelligence Development Plan" issued by the State Council in [year] specifically mentions 2025 In the coming year, major breakthroughs should be made in the basic theories of artificial intelligence. Some technologies and applications should reach world-leading levels. Artificial intelligence should become the main driving force for industrial upgrading and economic transformation in China. Active progress should be made in the construction of an intelligent society. It is particularly proposed that the scale of the core artificial intelligence industry should exceed 4,000 Yuan, driving the scale of related industries to exceed 5 trillion yuan; by 2030 In 2023, the overall theory, technology, and application of artificial intelligence should reach the world's leading level, becoming a major global center for artificial intelligence innovation. The intelligent economy and society should achieve significant results, laying an important foundation for China to rank among the forefront of innovative countries and become an economic powerhouse. Among these, the scale of the core artificial intelligence industry should exceed 1 trillion yuan, driving the scale of related industries to exceed 10 trillion yuan. In addition, in response to the specific challenges mentioned earlier, our country has also introduced a series of development policies. Taking 'East Data West Computing' as an example: 2021 year 5 month 24 On the same day, four ministries and commissions jointly issued the "Implementation Plan for the National Integrated Big Data Center Collaborative Innovation System Computing Power Hub," proposing the layout and construction of national integrated computing power network hub nodes, accelerating the implementation of the "East Data West Computing" project. Further network transmission channels will be opened up between national hub nodes to improve cross-regional computing power scheduling levels. Exploration and practice in cloud computing services, data circulation, data applications, security assurance, etc., will be strengthened to play a demonstrative and leading role, providing important assistance in solving China's computing power needs for artificial intelligence. Q What significant challenges and opportunities will traditional Chinese internet giants face?   In fact, during the development of artificial intelligence in our country, traditional Chinese internet giants (which are what we commonly refer to as Alibaba, Baidu, Tencent, Douyin Group, and JD.com) have not been absent. They have even become important participants in the infrastructure and application aspects of artificial intelligence in our country. Take Baidu as an example, 2018 Announced in “ All In AI After the strategic launch, Baidu has taken the lead in delivering a remarkable result in this year's large-scale language model competition. Although there is still room for improvement compared to foreign models, as a domestic vendor, it has made up for the shortcomings of foreign models in the Chinese language corpus environment. Baidu's Wenxin Large Model can generate excellent works for different fields based on different keyword and scenario requirements. For example, it can generate a beautiful painting by inputting a sentence or a description of text. 2022 year 7 In January, the Wenyang-textile-textile Large Model "completed" the missing scroll of the world-famous painting "The Song of Rich Spring," and also composed a poem, which elicited exclamations from everyone. After Baidu released the Wenxin Large Model, Alibaba Cloud also launched a large language model with hundreds of billions of parameters, "Tongyiquanwen" Integrating multimodal knowledge understanding, it possesses strong copywriting capabilities, and these abilities are applied to empower the office collaboration software DingTalk under Alibaba. DAMO Academy, an R&D institution under Alibaba, has always been at the forefront of artificial intelligence technology research in China, dedicated to exploring the unknown through technology and driven by human aspirations, conducting basic scientific research and innovative technology development. We believe that traditional internet giants have always been actively involved in the development of artificial intelligence in our country and will continue to be at the forefront of technological development. * This interview was published in Refinitiv Workspace   Reporters: Liu Luoyan, Lin Yuhuan. Original title: 'Analysis' AI The 'arms race' is in full swing, and China needs to break through the 'iron curtain' of technology    .

Recently, the Ministry of Industry and Information Technology stated that it is making forward-looking arrangements for artificial intelligence, Web3.0 Advanced computing, 6G In the future, industries will develop new competitiveness on new tracks.   Central enterprises have established nearly 500 The home focus is mainly on strategic emerging industries such as new-generation information technology and artificial intelligence. Currently, central enterprises have made outstanding achievements in deploying into strategic emerging industries, most recently 5 The average annual growth rate of investment in strategic emerging industries exceeds 20% .    Meanwhile, since the beginning of this year, the concept of China Special Economic Zone (SEZ) valuation has been hot, with central enterprise valuations rapidly returning to normal.   Why does the state strongly encourage central enterprises to develop strategic emerging industries?    In the context of exploring the establishment of a Sino-foreign joint venture valuation model, how can the layout of strategic emerging industries positively impact the valuation of central enterprises? Which emerging industry tracks are expected to be the first to embrace development opportunities?    Frost & Sullivan Frost & Sullivan Lu Jing, Partner and Managing Director of Frost & Sullivan's Greater China Region, was interviewed by Securities Daily to discuss the layout and development of strategic emerging industries.   * Click "Read the Original Article" at the end of this text to read the full report. Securities Daily Q Securities Daily Reporter: What are the advantages of central enterprises in developing strategic emerging industries?   Central enterprises possess characteristics such as high concentration, efficiency, large industrial scale, and significant influence. From the perspective of the capital market, central enterprises can assist in the national development of strategic emerging industries through two main methods. Firstly, central enterprises can improve the rapid layout of strategic emerging industries through mergers and reorganizations. By merging and reorganizing, they can accelerate the establishment of leading enterprises in emerging industries, thereby increasing industrial concentration and more effectively creating a complete industrial development environment. Secondly, central enterprises can also play a role in financing, raising funds for the development of strategic emerging industries through multiple channels such as issuing stocks or bonds, providing strong financial support for central enterprises to accelerate the development of strategic emerging industries. Overall, state-owned assets and central enterprises can concentrate funds and personnel to help form large-scale industrial clusters, thereby accelerating the overall layout of industries and improving the development environment. Therefore, it is of great significance that the state is currently strongly encouraging central enterprises to vigorously develop strategic emerging industries. Q Securities Daily Reporter: In the context of exploring the establishment of a Sino-Tibetan economic integration assessment, what positive role does the layout of strategic emerging industries play in enhancing the valuation of central enterprises? The Sino-Tsinghua Enterprise Evaluation (STE) can effectively address the reality that state-owned enterprises have been undervalued for a long time. Unlike traditional valuation systems, the STE system reduces its focus on the profitability of enterprises themselves and places more emphasis on improving the efficiency of profitability. State-owned assets enterprises are vigorously deploying in strategic emerging industries. With the continuous catalytic promotion of policies, these emerging industries show obvious growth potential, thereby increasing expectations for the profitability efficiency of state-owned central enterprises. This will have a positive effect on enhancing the valuation of central enterprises. By raising the valuation level of central enterprises, more market funds are attracted into them, providing financial support for the development of central enterprises themselves. Central enterprises then feed back and assist in the development of emerging industries, thus forming a virtuous development cycle. Q Securities Daily Reporter: According to the State-owned Assets Supervision and Administration Commission (SASAC), a package of policies to support the development of strategic emerging industries by central enterprises will be introduced. Against this backdrop, which emerging industry tracks are expected to be the first to embrace development opportunities?   State-owned Assets Supervision and Administration Commission 2 month and 5 Since [month], several policies have been introduced to promote the development of emerging industries. Against this policy backdrop, industries closely related to national strategies, such as integrated circuits, artificial intelligence, and information technology, will attract more market capital inflows, thereby accelerating the industrial development layout. Especially, digital technology industries are set to lead the way in embracing new development opportunities. Since digital technology industries can effectively boost the efficient development of other industries, they act as a catalyst for industrial growth. For instance, traditional industries can significantly enhance their analytical and computational capabilities during the equipment R&D process with the superposition and empowerment of new-generation information technology, thereby accelerating R&D innovation efficiency. At the same time, related technologies can also improve the collection and analysis of massive industrial data, promoting quality improvement, efficiency enhancement, and cost reduction in related manufacturing processes. Therefore, digital technology industries, which can help other emerging industries and act as a catalyst, are set to quickly deploy first under policy promotion, attracting development opportunities. * This interview was published in Securities Daily.   The reporter is Xing Meng, and the original title was 'Continuously Increasing Investment in Strategic Emerging Industries Boosting the Accelerated Return of Central Enterprises' Overall Valuation    .